Christina Poh, MD

Dr Christina Poh | Image Credit: Lymphoma Research Foundation

Christina Poh, MD, is a physician and clinical researcher at City of Hope National Medical Center.

Articles by Christina Poh, MD

Tafasitamab Approval Expands Chemotherapy-Free Treatment Options for R/R Follicular Lymphoma: Christina Poh, MD

August 8th 2025

Christina Poh, MD, of City of Hope National Medical Center, highlights the benefit of tafasitamab in improving progression-free survival for heavily pretreated patients with relapsed or refractory (R/R) follicular lymphoma.

Christina Poh, MD

Articles by Christina Poh, MD

Tafasitamab Approval Expands Chemotherapy-Free Treatment Options for R/R Follicular Lymphoma: Christina Poh, MD

Latest Updated Articles

Trending on AJMC

Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home

Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301